Human annulus progenitor cells: Analyses of this viable endogenous cell population

Back pain and intervertebral disc degeneration have growing socioeconomic/health care impacts. Increasing research efforts address use of stem and progenitor cell‐based replacement therapies to repopulate and regenerate the disc. Data presented here on the innate human annulus progenitor cells: (i) assessed osteogenic, chondrogenic and adipogenic potentials of cultured human annulus cells; and (ii) defined progenitor‐cell related gene expression patterns. Verification of the presence of progenitor cells within primary human disc tissue also used immunohistochemical identification of cell surface markers and microarray analyses. Differentiation analysis in cell cultures demonstrated a viable progenitor cell pool within Thompson grades III–IV discs. Osteogenesis was present in 8 out of 11 cultures (73%), chondrogenesis in 8 of 11 (73%), and adipogenesis in 6 of 6 (100%). Immunolocalization was positive for CD29, CD44, CD105, and CD14 (mean values 80.2%, 81.5%, 85.1%, and 88.6%, respectively); localization of CD45 and CD34 was negative in disc tissue. Compared to controls, surgical discs showed significantly downregulated genes with recognized progenitor cell functions: TCF7L2 (2.7 fold), BMI1 (3.8 fold), FGF receptor 2 (2 fold), PAFAH1B1 (2.3 fold), and GSTP1 (9 fold). Compared to healthier grade I/II discs, grade III/IV discs showed significantly upregulated XRCC5 (3.6 fold), TCF7L2 (6 fold), GSTP1 (3.7 fold), and BMI1 (3 fold). Additional significant cell marker analyses showed expression of platelet‐derived growth factor receptor alpha, CD90, CD73, and STRO‐1. Statement of Clinical Significance: Findings provide the first identification of progenitor cells in annulus specimens from older, more degenerate discs (in contrast to earlier studies of healthier discs or nondegenerative specimens from teenagers). Findings also increase knowledge on progenitor cells present in the disc and suggest their value in potential future utilization for regeneration and disc cell therapy. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1351–1360, 2016.

[1]  S. Morrison,et al.  A perisinusoidal niche for extramedullary haematopoiesis in the spleen , 2015, Nature.

[2]  H. Sytwu,et al.  Hypoxia Induces a Metabolic Shift and Enhances the Stemness and Expansion of Cochlear Spiral Ganglion Stem/Progenitor Cells , 2015, BioMed research international.

[3]  J. Fairclough,et al.  Evidence of a Viable Pool of Stem Cells within Human Osteoarthritic Cartilage , 2014, Cartilage.

[4]  H. Gruber,et al.  Growth and differentiation factor-5 (GDF-5) in the human intervertebral annulus cells and its modulation by IL-1ß and TNF-α in vitro. , 2014, Experimental and molecular pathology.

[5]  Keisuke Ito,et al.  Metabolic requirements for the maintenance of self-renewing stem cells , 2014, Nature Reviews Molecular Cell Biology.

[6]  K. Luk,et al.  The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc. , 2013, The spine journal : official journal of the North American Spine Society.

[7]  D. Drazin,et al.  Stem Cell Therapy for Degenerative Disc Disease , 2012, Advances in orthopedics.

[8]  Rocky S Tuan,et al.  Concise Review: The Clinical Application of Mesenchymal Stem Cells for Musculoskeletal Regeneration: Current Status and Perspectives , 2012, Stem cells translational medicine.

[9]  R. Iozzo,et al.  The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. , 2012, Blood.

[10]  H. Okano,et al.  Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc , 2012, Nature Communications.

[11]  L. Engebretsen,et al.  Bone and Cartilage from Stem Cells: Growth Optimalization and Stabilization of Cell Phenotypes , 2011 .

[12]  A. Brandl,et al.  Oxidative stress induces senescence in human mesenchymal stem cells. , 2011, Experimental cell research.

[13]  J. Andrades,et al.  The Stem Cell Niche Should be a Key Issue for Cell Therapy in Regenerative Medicine , 2011, Stem Cell Reviews and Reports.

[14]  P. Bianco.  Minireview: The stem cell next door: skeletal and hematopoietic stem cell "niches" in bone. , 2011, Endocrinology.

[15]  Janet Rossant,et al.  The role of FGF/Erk signaling in pluripotent cells , 2010, Development.

[16]  E. Laborde.  Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death , 2010, Cell Death and Differentiation.

[17]  H. Gruber,et al.  Human adipose-derived mesenchymal stem cells: direction to a phenotype sharing similarities with the disc, gene expression profiling, and coculture with human annulus cells. , 2010, Tissue engineering. Part A.

[18]  C. Laurencin,et al.  Multipotential differentiation of human anulus fibrosus cells: an in vitro study. , 2010, The Journal of bone and joint surgery. American volume.

[19]  P. Fortina,et al.  Reversine enhances generation of progenitor-like cells by dedifferentiation of annulus fibrosus cells. , 2010, Tissue engineering. Part A.

[20]  A. Lindahl,et al.  Identification of Cell Proliferation Zones, Progenitor Cells and a Potential Stem Cell Niche in the Intervertebral Disc Region: A Study in Four Species , 2009, Spine.

[21]  H. Gruber,et al.  Adipose-Derived Stem Cells: Characterization and Current Application in Orthopaedic Tissue Repair , 2009, Experimental biology and medicine.

[22]  H. Gruber,et al.  Adipose-derived mesenchymal stem cells from the sand rat: transforming growth factor beta and 3D co-culture with human disc cells stimulate proteoglycan and collagen type I rich extracellular matrix , 2008, Arthritis research & therapy.

[23]  J. Iatridis,et al.  Behavior of Mesenchymal Stem Cells in the Chemical Microenvironment of the Intervertebral Disc , 2008, Spine.

[24]  H. Gruber,et al.  IGF-1 rescues human intervertebral annulus cells from in vitro stress-induced premature senescence , 2008, Growth factors.

[25]  T. Albert,et al.  Evidence for Skeletal Progenitor Cells in the Degenerate Human Intervertebral Disc , 2007, Spine.

[26]  Sean C. Bendall,et al.  IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro , 2007, Nature.

[27]  Chan‐Wha Kim,et al.  Proteome of mesenchymal stem cells , 2007, Proteomics.

[28]  J. Lotz,et al.  The potential role of mesenchymal stem cell therapy for intervertebral disc degeneration: a critical overview. , 2005, Neurosurgical focus.

[29]  Sean J Morrison,et al.  Bmi1, stem cells, and senescence regulation. , 2004, The Journal of clinical investigation.

[30]  H. Gruber,et al.  Cell-based tissue engineering for the intervertebral disc: in vitro studies of human disc cell gene expression and matrix production within selected cell carriers. , 2004, The spine journal : official journal of the North American Spine Society.

[31]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[32]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[33]  Hans Clevers,et al.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 , 1998, Nature Genetics.

[34]  H. Gruber,et al.  Characterization and phenotypic stability of human disc cells in vitro. , 1997, Matrix Biology.

[35]  H E Gruber,et al.  Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. , 1997, Experimental cell research.

[36]  I. Mcniece,et al.  Stem cell factor , 1995, Journal of leukocyte biology.

[37]  J. T. Thomas,et al.  Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. , 1994, The Journal of biological chemistry.

[38]  J. P. Thompson,et al.  Preliminary Evaluation of a Scheme for Grading the Gross Morphology of the Human Intervertebral Disc , 1990, Spine.

[39]  N. Gotoh.  Control of stemness by fibroblast growth factor signaling in stem cells and cancer stem cells. , 2009, Current stem cell research & therapy.

[40]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[41]  S. Richardson,et al.  Stem Cell Regeneration of Degenerated Intervertebral Discs: Current Status (Update) , 2008, Current Pain and Headache Reports.